CD39 and CD73 are highly expressed on Treg and tumor cells, leading to the accumulation of extracellular adenosine and thereby inhibiting the activation of effector T cells with up-regulated A2AR in the TME while enhancing the activity of Treg (128). Here, ADORA2A is linked to neoplasm.